Corteva Inc
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Goodwill and Other Intangible Assets
NOTE 13 -GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table summarizes changes in the carrying amount of goodwill by segment for the years ended December 31, 2023 and 2024, respectively.
| (In millions) | Crop Protection | Seed | Total |
|---|---|---|---|
| Balance as of December 31, 2022 | $4,618 | $5,344 | $9,962 |
| Acquisitions1 | 512 | — | 512 |
| Currency translation adjustment | 53 | 78 | 131 |
| Balance as of December 31, 2023 | $5,183 | $5,422 | $10,605 |
| Currency translation adjustment | (139) | (96) | (235) |
| Other goodwill adjustments2 | 38 | — | 38 |
| Balance as of December 31, 2024 | $5,082 | $5,326 | $10,408 |
On March 1, 2023, the company completed the acquisitions of Stoller and Symborg, which are included in the Crop Protection segment. See Note 4 – Business Combinations, to the Consolidated Financial Statements, for additional information.
Includes measurement period adjustments related to the acquisitions of Stoller and Symborg, which were not material.
The company performed annual qualitative testing on all of its reporting units in 2024 and quantitative testing on all of its reporting units in 2023, determining that no goodwill impairments existed in either year. As of December 31, 2024, accumulated impairment losses on goodwill were $4,503 million.
Other Intangible Assets
The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows:
| (In millions) | December 31, 2024 | December 31, 20231 | ||||
|---|---|---|---|---|---|---|
| Gross | AccumulatedAmortization | Net | Gross | AccumulatedAmortization | Net | |
| Intangible assets subject to amortization (finite-lived): | ||||||
| Germplasm | $6,291 | $(1,336) | $4,955 | $6,291 | $(1,081) | $5,210 |
| Customer-related | 2,350 | (863) | 1,487 | 2,427 | (734) | 1,693 |
| Developed technology | 1,838 | (1,161) | 677 | 1,849 | (1,004) | 845 |
| Trademarks/trade names | 2,056 | (380) | 1,676 | 2,111 | (339) | 1,772 |
| Other2 | 388 | (312) | 76 | 395 | (294) | 101 |
| Total other intangible assets with finite lives | $12,923 | $(4,052) | $8,871 | $13,073 | $(3,452) | $9,621 |
| Intangible assets not subject to amortization (indefinite-lived): | ||||||
| In-process research and development | 5 | — | 5 | 5 | — | 5 |
| Total other intangible assets with indefinite lives | 5 | — | 5 | 5 | — | 5 |
| Total other intangible assets | $12,928 | $(4,052) | $8,876 | $13,078 | $(3,452) | $9,626 |
Includes the intangible assets acquired in connection with the Stoller and Symborg acquisitions, which were completed on March 1, 2023. See Note 4 – Business Combinations, to the Consolidated Financial Statements, for additional information.
Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
The aggregate pre-tax amortization expense from continuing operations for finite-lived intangible assets was $685 million, $683 million, and $702 million, for the years ended December 31, 2024, 2023, and 2022, respectively.
Total estimated amortization expense for the next five fiscal years is as follows:
| (In millions) | |
|---|---|
| 2025 | $641 |
| 2026 | 631 |
| 2027 | 570 |
| 2028 | 549 |
| 2029 | 526 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.